Simple jQuery Dropdowns

Browsing by Author Fundacion Huesped

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
1-Jan-2014Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO studyGareth Tudor-Williams; Pedro Cahn; Kulkanya Chokephaibulkit; Jan Fourie; Chris Karatzios; S. Dincq; M. Opsomer; T. N. Kakuda; S. Nijs; L. Tambuyzer; F. L. Tomaka; Rosa Bologna; Esaú João; José Henrique Pilotto; Marisa Mussi-Pinhata; Jorge Pinto; Normand Lapointe; Albert Faye; Kamila Kebaili; Steven Welch; Stefania Bernardi; Luisa Galli; Carlo Giaquinto; Nicola Principi; Gian Vincenzo Zuccotti; Henriette J. Scherpbier; Laura Marques; Isabel Soares; Margarida Tavares; Midnela Acevedo; Dan Duiculescu; Sorin Rugina; Gulam H. Latiff; Claudia Fortuny; Juan Antonio Leon Leal; Marissa Navarro; Jose T. Ramos; Tawee Chotpitayasunondh; Pope Kosalaraksa; Kiat Ruxrungtham; Jacobo Abadi; Tess Barton; William Borkowsy; Janet Chen; Joseph Church; Patricia Flynn; Sohail Rana; Richard Rutstein; Leonard Weiner; Imperial College London; Fundacion Huesped; Mahidol University; Dr Jan Fourie Medical Practice; Centre universitaire de sante McGill; Janssen Infectious Diseases BVBA; Janssen
1-Jul-2004Predictors of adherence and virologic outcome in HIV-infected patients treated with abacavir- or indinavir-based triple combination HAART also containing lamivudine/zidovudinePedro Cahn; Asda Vibhagool; Mauro Schechter; Luis Soto-Ramirez; Giampiero Carosi; Fiona Smaill; Jamie C. Jordan; Cristina E. Pharo; Nicola E. Thomas; Helen M. Steel; Fundacion Huesped; Mahidol University; Universidade Federal do Rio de Janeiro; Instituto Nacional de la Nutricion Salvador Zubiran; Universita degli Studi di Brescia; McMaster University Medical Centre; GlaxoSmithKline, USA; GlaxoSmithKline plc, United Kingdom
1-Nov-2017Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trialPedro Cahn; Richard Kaplan; Paul E. Sax; Kathleen Squires; Jean Michel Molina; Anchalee Avihingsanon; Winai Ratanasuwan; Evelyn Rojas; Mohammed Rassool; Mark Bloch; Linos Vandekerckhove; Peter Ruane; Yazdan Yazdanpanah; Christine Katlama; Xia Xu; Anthony Rodgers; Lilly East; Larissa Wenning; Sandy Rawlins; Brenda Homony; Peter Sklar; Bach Yen Nguyen; Randi Leavitt; Hedy Teppler; P. E. Cahn; I. Cassetti; M. Losso; M. T. Bloch; N. Roth; J. McMahon; R. J. Moore; D. Smith; N. Clumeck; L. Vanderkerckhove; B. Vandercam; M. Moutschen; J. Baril; B. Conway; F. Smaill; G. H.R. Smith; A. Rachlis; S. L. Walmsley; C. Perez; M. Wolff; M. F. Lasso; C. E. Chahin; J. D. Velez; O. Sussmann; J. Reynes; C. Katlama; Y. Yazdanpanah; S. Ferret; J. Durant; C. Duvivier; I. Poizot-Martin; F. Ajana; J. K. Rockstroh; G. Faetkanheuer; S. Esser; H. Jaeger; O. Degen; M. Bickel; J. Bogner; K. Arasteh; H. Hartl; A. Stoehr; E. M. Rojas; E. Arathoon; L. D. Gonzalez; C. R. Mejia; E. Shahar; D. Turner; I. Levy; Z. Sthoeger; H. Elinav; A. Gori; A. D.Arminio Monforte; G. Di Perri; A. Lazzarin; G. Rizzardini; A. Antinori; B. M. Celesia; F. Maggiolo; T. S. Chow; C. K.C. Lee; R. Iskandar Shah Raja Azwa; M. Mustafa; M. Oyanguren; R. A. Castillo; L. Hercilla; C. Echiverri; F. Maltez; JG Saraiva da Cunha; I. Neves; E. Teofilo; R. Serrao; F. Nagimova; I. Khaertynova; E. Orlova-Morozova; E. Voronin; Fundacion Huesped; Desmond Tutu HIV Foundation; Brigham and Women's Hospital; Thomas Jefferson University; Hôpital Saint-Louis; Chulalongkorn University; Mahidol University; Cericap Multiclinicas; University of Witwatersrand; Holdsworth House Medical Practice; Universiteit Ghent, Faculteit Geneeskunde en Gezondheidswetenschappen; Ruane Medical and Liver Health Institute; Hôpital Bichat-Claude-Bernard AP-HP; Hôpital Universitaire Pitié Salpêtrière; Merck & Co., Inc.
15-Aug-2018Raltegravir 1200 mg once daily vs 400 mg twice daily, with emtricitabine and tenofovir disoproxil fumarate, for previously untreated HIV-1 infection: Week 96 results from ONCEMRK, a randomized, double-blind, noninferiority trialPedro Cahn; Paul E. Sax; Kathleen Squires; Jean Michel Molina; Winai Ratanasuwan; Mohammed Rassool; Mark Bloch; Xia Xu; Yan Zhou; Brenda Homony; Deborah Hepler; Hedy Teppler; George J. Hanna; Bach Yen Nguyen; Wayne Greaves; Fundacion Huesped; Brigham and Women's Hospital; University of Witwatersrand; Thomas Jefferson University; Faculty of Medicine, Siriraj Hospital, Mahidol University; Merck & Co., Inc.; Universite Paris 7- Denis Diderot; Holdsworth House Medical Practice
1-Jul-2004Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: Results of a 48-week open-label, equivalence trial (CNA3014)Asda Vibhagool; Pedro Cahn; Mauro Schechter; Fiona Smaill; Luis Soto-Ramirez; Giampiero Carosi; Maria Montroni; Cristina E. Pharo; Jamie C. Jordan; Nicola E. Thomas; Gill Pearce; Mahidol University; Fundacion Huesped; Universidade Federal do Rio de Janeiro; McMaster University Medical Centre; Instituto Nacional de la Nutricion Salvador Zubiran; Clin. Malat. Infettive e Tropicalli; Ospedale Umberto I, Ancona; GlaxoSmithKline plc, United Kingdom; GlaxoSmithKline, USA
17-Oct-2013Tuberculosis in Antiretroviral Treatment Programs in Lower Income Countries: Availability and Use of Diagnostics and ScreeningLukas Fenner; Marie Ballif; Claire Graber; Venerandah Nhandu; Jean Claude Dusingize; Claudia P. Cortes; Gabriela Carriquiry; Kathryn Anastos; Daniela Garone; Eefje Jong; Joachim Charles Gnokoro; Omar Sued; Samuel Ajayi; Lameck Diero; Kara Wools-Kaloustian; Sasisopin Kiertiburanakul; Barbara Castelnuovo; Charlotte Lewden; Nicolas Durier; Timothy R. Sterling; Matthias Egger; Institut fur Sozial- und Praventivmedizin; Swiss Tropical and Public Health Institute (Swiss TPH); Universitat Basel; Centre for Infectious Disease Research in Zambia; Women's Equity in Access to Care and Treatment; Facultad de Medicina de la Universidad de Chile; Universidad Peruana Cayetano Heredia, Instituto de Medicina Tropical Alexander von Humboldt; Albert Einstein College of Medicine of Yeshiva University; Khayelitsha ART Programme; University of Witwatersrand; CEPREF ART Program; Fundacion Huesped; University of Abuja; USAID AMPATH; Indiana University-Purdue University Indianapolis; Mahidol University; Infections Diseases Institute; University Bordeaux Segalen; amfAR - The Foundation for AIDS Research; Vanderbilt University School of Medicine